R, M., JF, A., T, F., N, L., J, A., M, H., . . . M, P. (2002). Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel. TheScientificWorldJournal, 2, 19. https://doi.org/10.1100/tsw.2002.10
Chicago Style (17th ed.) CitationR, Mirhashemi, Arena JF, Frudakis T, Lambrou N, Arboleda J, Hunt M, Medranda M, Averette H, and Penalver M. "Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel." TheScientificWorldJournal 2 (2002): 19. https://doi.org/10.1100/tsw.2002.10.
MLA (9th ed.) CitationR, Mirhashemi, et al. "Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel." TheScientificWorldJournal, vol. 2, 2002, p. 19, https://doi.org/10.1100/tsw.2002.10.